Výsledky vyhledávání

Akademický článek

Spotlight on ramucirumab in the treatment of nonsmall cell lung cancer: design, development, and clinical activity

Autor: Cobo M, Gutiérrez V, Villatoro R, Trigo JM, Ramos I, López O, Ruiz M, Godoy A, López I, Arroyo M

Publikováno v: Lung Cancer: Targets and Therapy, Vol Volume 8, Pp 57-66 (2017)

Manuel Cobo,1 Vanesa Gutiérrez,1 Rosa Villatoro,2 Jose Manuel Trigo,1 Inmaculada Ramos,1 Omar López,1 María Ruiz,1 Ana Godoy,1 Irene López,1 Macarena Arroyo3 1Medical Oncology Department, Hospital Universitario Málaga Regional y Virgen de la Vic

Externí odkaz: https://doaj.org/article/9ce6e473f41f4ac5838784a2d4df92bc

Zobrazit plný text záznamu

A consensus statement on the gender perspective in lung cancer

Publikováno v: Clinical & Translational Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
CLINICAL & TRANSLATIONAL ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe

Lung cancer is the most common cancer globally and has the highest mortality. Although this disease is not associated with a particular gender, its incidence is rising among women, who are diagnosed at an increasingly younger age compared with men. O

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::53a23de1f8b50b32011364564ee23eac
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6466

Zobrazit plný text záznamu

Akademický článek

Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments.

Autor: Elhabazi, K¹, Trigo, JM², Mollereau, C³, Moulédous, L³, Zajac, J-M³, Bihel, F⁴, Schmitt, M⁴, Bourguignon, JJ⁴, Meziane, H⁵, Petit-demoulière, B⁵, Bockel, F⁶, Maldonado, R², Simonin, F¹

Publikováno v: British Journal of Pharmacology. Jan2012, Vol. 165 Issue 2, p424-435. 12p. 6 Graphs.

Zobrazit plný text záznamu

Recommendations from the Spanish Oncology Genitourinary Group for the treatment of metastatic renal cancer

Autor: Bellmunt, J, Calvo, E, Castellano, D, Climent, MA, Esteban, E, del Muro, XG, Gonzalez-Larriba, JL, Maroto, P, Trigo, JM

Publikováno v: CANCER CHEMOTHERAPY AND PHARMACOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

For almost the last two decades, interleukin-2 and interferon-alpha have been the only systemic treatment options available for metastatic renal cell carcinoma. However, in recent years, five new targeted therapies namely sunitinib, sorafenib, temsir

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::9db9f41ab39728650b6d9dbbba61b657
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=13368

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání